HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qingdi Q Li Selected Research

Immunosorbents

5/2004Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qingdi Q Li Research Topics

Disease

14Neoplasms (Cancer)
07/2009 - 03/2004
10Carcinoma (Carcinomatosis)
07/2009 - 05/2004
7Leukemia
07/2009 - 09/2002
4Ovarian Neoplasms (Ovarian Cancer)
05/2005 - 05/2004
3Lung Neoplasms (Lung Cancer)
07/2009 - 07/2005
3Carcinogenesis
01/2007 - 03/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2009 - 11/2004
2Glioma (Gliomas)
03/2007 - 05/2006
2Stomach Neoplasms (Stomach Cancer)
01/2007 - 05/2005
2Bacteremia
02/2006 - 02/2006
2Infections
02/2006 - 02/2006
1Lymphoid Leukemia
06/2007
1Adenoviridae Infections (Adenovirus Infections)
03/2007
1Graves Ophthalmopathy
05/2006
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2005
1Prostatic Neoplasms (Prostate Cancer)
07/2004
1Neoplasm Metastasis (Metastasis)
05/2004
1Breast Neoplasms (Breast Cancer)
03/2004
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2004
1Ganglion Cysts (Ganglion)
01/2004
1Necrosis
10/2003

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
07/2009 - 08/2004
5Pharmaceutical PreparationsIBA
08/2007 - 08/2004
3Antineoplastic Agents (Antineoplastics)IBA
07/2009 - 11/2004
3Biomarkers (Surrogate Marker)IBA
01/2007 - 05/2004
3Paclitaxel (Taxol)FDA LinkGeneric
07/2005 - 08/2004
2beta-elemeneIBA
07/2009 - 08/2007
2Docetaxel (Taxotere)FDA Link
08/2007 - 07/2005
2taxaneIBA
08/2007 - 07/2005
2Taxoids (Taxanes)IBA
08/2007 - 07/2005
2Annexin A5IBA
06/2007 - 09/2005
2Telomerase (Telomerase Reverse Transcriptase)IBA
03/2007 - 05/2006
2Carboplatin (JM8)FDA LinkGeneric
05/2005 - 08/2004
2Cyclin EIBA
09/2004 - 09/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004 - 05/2004
1Propidium (Propidium Iodide)IBA
06/2007
1CamptothecinIBA
06/2007
1Arsenic Trioxide (Trisenox)FDA Link
06/2007
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2007
1ArsenicIBA
06/2007
1Fas Ligand Protein (Fas Ligand)IBA
06/2007
1Proteins (Proteins, Gene)FDA Link
03/2007
1E2F1 Transcription FactorIBA
01/2007
1telomerase RNA (bTR)IBA
05/2006
1Antisense OligonucleotidesIBA
05/2006
1Messenger RNA (mRNA)IBA
05/2006
1Complementary DNA (cDNA)IBA
05/2006
1N 30IBA
02/2006
1beta-Lactamases (beta-Lactamase)IBA
02/2006
1ImipenemFDA Link
02/2006
1CyclinsIBA
10/2005
1Caspase 3 (Caspase-3)IBA
09/2005
1Bromodeoxyuridine (BrdU)IBA
05/2005
1Genetic Markers (Genetic Marker)IBA
05/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2005
1Caffeine (No Doz)FDA LinkGeneric
09/2004
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2004
1multidrug resistance-associated protein 1IBA
08/2004
1Semaxinib (SU5416)IBA
08/2004
1trioctyl phosphine oxide (TOPO)IBA
08/2004
1Biological ProductsIBA
08/2004
1PlatinumIBA
08/2004
1NF-kappa B (NF-kB)IBA
07/2004
1AndrogensIBA
07/2004
1CaspasesIBA
07/2004
1EnzymesIBA
05/2004
1Tumor Biomarkers (Tumor Markers)IBA
05/2004
1ImmunosorbentsIBA
05/2004
1Cyclin B1IBA
03/2004
1Retinaldehyde (Retinal)IBA
01/2004
1Dinoprostone (PGE2)FDA Link
10/2003
1Vinblastine (Vinblastine Sulfate)FDA Link
09/2002
1A-Form DNA (A-DNA)IBA
09/2002

Therapy/Procedure

6Therapeutics
03/2007 - 05/2004
4Drug Therapy (Chemotherapy)
07/2005 - 11/2004
1Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2007
1Injections
02/2006
1Phage Therapy
02/2006